VACCINE AND TREATMENT EVALUATION UNITS: HANTAVIRUS VACCINE CLINICAL TRIAL

疫苗和治疗评估单位：汉坦病毒疫苗临床试验

• 批准号: 9571158
• 负责人: DAVID BERNSTEIN
• 金额: $ 127.83万
• 依托单位: CINCINNATI CHILDRENS HOSP MED CTR
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-06-12 至 2020-03-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9571158
• 关键词: Communicable Diseases; Conduct Clinical Trials; Contracts; Evaluation; Hantavirus; Individual; Phase; Population; Resources; Vaccine Clinical Trial; Vaccines; combat; design; named group; programs

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.

该计划由学术中心和组织内的个人合同联盟组成，为临床试验的设计和实施提供现成的资源，以评估有前景的抗击传染病的产品。一般来说，产品会在正常健康人群中进行评估；然而，也可以接触特殊人群。